DocuSign, Inc. (DOCU) shareholders
Close on Nov 13, 2026Market cap $15.09BP/E 49.2Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 20,722,495 | 10.70% | 13G (passive) amendment | Mar 31, 2026 |
| Vanguard Portfolio Management | 11,385,156 | 5.85% | 13G (passive) | Mar 31, 2026 |
| Vanguard Capital Management | 10,756,040 | 5.53% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of DOCU | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 20,870,306 | 11.17% | $927.06M | −693,831 | 0.01% |
| Vanguard Portfolio Management LLC | 11,594,282 | 6.20% | $515.02M | +306,984 | 0.02% |
| Aqr Capital Management LLC | 8,972,591 | 4.80% | $398.56M | +4,128,800 | 0.14% |
| Vanguard Capital Management LLC | 8,770,642 | 4.69% | $389.59M | −184,572 | 0.01% |
| Capital World Investors | 7,055,601 | 3.78% | $313.41M | +15,796 | 0.04% |
| State Street Corp | 6,283,069 | 3.36% | $279.09M | −543,667 | 0.01% |
| Ameriprise Financial Inc | 6,165,568 | 3.30% | $273.93M | +2,129,192 | 0.06% |
| Arrowstreet Capital, Limited Partnership | 5,581,037 | 2.99% | $247.91M | +295,909 | 0.11% |
| Geode Capital Management, LLC | 4,112,381 | 2.20% | $184.38M | −46,879 | 0.01% |
| Federated Hermes, Inc. | 3,334,645 | 1.78% | $148.12M | +1,446,745 | 0.21% |
| Price T Rowe Associates Inc /Md/ | 3,332,042 | 1.78% | $148.01M | +34,030 | 0.01% |
| Two Sigma Investments, LP | 3,301,509 | 1.77% | $146.65M | +1,531,101 | 0.11% |
| Renaissance Technologies LLC | 3,075,061 | 1.65% | $136.59M | −95,000 | 0.19% |
| FMR LLC | 3,070,318 | 1.64% | $136.38M | +671,453 | 0.01% |
| Invesco Ltd. | 2,881,241 | 1.54% | $127.98M | +1,757,909 | 0.01% |
| Morgan Stanley | 2,801,981 | 1.50% | $124.46M | +44,825 | 0.01% |
| Norges Bank | 2,446,076 | 1.31% | $108.65M | New | 0.01% |
| UBS Group AG | 2,209,283 | 1.18% | $98.14M | +49,185 | 0.01% |
| Jacobs Levy Equity Management, Inc | 2,043,909 | 1.09% | $90.79M | +96,197 | 0.33% |
| Goldman Sachs Group Inc | 1,976,770 | 1.06% | $87.81M | −1,078,489 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 672 | 176M | 94.4% | 92 / 239 | 246 / 114 | 25M | 28M |
| Q1 2026 | 708 | 179M | 95.9% | 103 / 276 | 230 / 169 | 64M | 33M |
| Q4 2025 | 787 | 170M | 90.9% | 109 / 260 | 306 / 122 | 23M | 23M |
| Q3 2025 | 815 | 171M | 91.4% | 131 / 275 | 291 / 88 | 15M | 22M |
| Q2 2025 | 781 | 178M | 95.1% | 92 / 287 | 278 / 109 | 20M | 15M |
| Q1 2025 | 809 | 173M | 92.7% | 117 / 277 | 289 / 113 | 14M | 17M |
| Q4 2024 | 818 | 177M | 94.6% | 221 / 264 | 234 / 87 | 44M | 32M |
| Q3 2024 | 694 | 165M | 88.1% | 108 / 221 | 247 / 75 | 34M | 17M |
| Q2 2024 | 667 | 162M | 86.8% | 77 / 241 | 222 / 88 | 22M | 27M |
| Q1 2024 | 685 | 168M | 89.7% | 90 / 241 | 238 / 103 | 28M | 25M |
| Q4 2023 | 707 | 166M | 88.7% | 147 / 204 | 267 / 91 | 31M | 15M |
| Q3 2023 | 664 | 151M | 80.6% | 73 / 216 | 247 / 110 | 20M | 28M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
495 funds held DOCU in Q2 2026, 57% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of DOCU | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 6,649,019 | 3.56% | $295.35M | 0.24% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 6,168,844 | 3.30% | $274.02M | 0.01% | Jun 30, 2026 |
| Growth Fund of America | 5,281,035 | 2.83% | $277.36M | 0.08% | May 31, 2026 |
| Vanguard Small-Cap Index Fund | 4,455,741 | 2.38% | $197.92M | 0.10% | Jun 30, 2026 |
| Columbia Seligman Technology and Information Fund | 2,913,147 | 1.56% | $153.00M | 0.54% | May 31, 2026 |
| Vanguard Information Technology Index Fund | 2,820,650 | 1.51% | $148.14M | 0.09% | May 31, 2026 |
| Vanguard Small-Cap Growth Index Fund | 2,562,845 | 1.37% | $113.84M | 0.24% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 2,228,280 | 1.19% | $98.98M | 0.10% | Jun 30, 2026 |
| T. Rowe Price Mid-Cap Value Fund, Inc. | 1,662,212 | 0.89% | $73.84M | 0.45% | Jun 30, 2026 |
| Growth Fund | 1,607,111 | 0.86% | $71.39M | 0.12% | Jun 30, 2026 |
| Invesco S&P MidCap Quality ETF | 1,462,366 | 0.78% | $80.18M | 1.47% | Jul 31, 2026 |
| Federated Hermes MDT Mid Cap Growth Fund | 1,087,064 | 0.58% | $59.60M | 0.90% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 1,031,317 | 0.55% | $54.16M | 0.13% | May 31, 2026 |
| iShares Expanded Tech-Software Sector ETF | 995,141 | 0.53% | $44.20M | 0.33% | Jun 30, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF | 983,468 | 0.53% | $43.69M | 0.24% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Allan C. Thygesen | President and CEO, Director | 166,801 | 0.09% | Oct 2, 2026 |
| Paula Hansen | Chief Revenue Officer | 103,258 | 0.06% | Nov 3, 2026 |
| James P. Shaughnessy | Chief Legal Officer | 50,591 | 0.03% | Oct 2, 2026 |
| Robert Chatwani | President General Mgr, Growth | 86,560 | 0.05% | Sep 21, 2026 |
| Blake Jeffrey Grayson | Chief Financial Officer | 107,933 | 0.06% | Sep 16, 2026 |
| Rowan M. Trollope | Director | 1,739 | 0.00% | Nov 3, 2026 |
| Mary Agnes Wilderotter | Director | 59,532 | 0.03% | Oct 2, 2026 |
| Anna Marrs | Director | 13,525 | 0.01% | Sep 15, 2026 |
| Peter Solvik | Director | 156,338 | 0.08% | Sep 11, 2026 |
| Teresa Briggs | Director | 10,811 | 0.01% | Sep 11, 2026 |
| Brian Keith Roberts | Director | 1,711 | 0.00% | Sep 8, 2026 |
| Michael George Rosenbaum | Director | 2,088 | 0.00% | Sep 3, 2026 |
| James A. Beer | Director | 21,225 | 0.01% | Sep 3, 2026 |
| Cain A. Hayes | Director | 16,813 | 0.01% | Sep 3, 2026 |
| Enrique T. Salem | Director | 168,414 | 0.09% | Sep 3, 2026 |
| Blake Irving | Director | 27,189 | 0.01% | Sep 3, 2026 |
| Daniel D. Springer | Director | 1,051,104 | 0.56% | Mar 18, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Paula Hansen Chief Revenue Officer | Nov 2, 2026 | Sale(10b5-1 plan) | −3,300 | $81.82 | $270.01K | 103,258 |
| Rowan M. Trollope Director | Nov 2, 2026 | Option exercise | +870 | – | – | 1,739 |
| Paula Hansen Chief Revenue Officer | Oct 5, 2026 | Award | +1 | $40.84 | $41 | 106,558 |
| Paula Hansen Chief Revenue Officer | Oct 1, 2026 | Sale(10b5-1 plan) | −300 | $69.37 | $20.81K | 106,557 |
| Paula Hansen Chief Revenue Officer | Oct 1, 2026 | Sale(10b5-1 plan) | −3,000 | $68.75 | $206.25K | 106,857 |
| Allan C. Thygesen President and CEO, Director | Oct 1, 2026 | Sale(10b5-1 plan) | −5,177 | $69.98 | $362.29K | 166,801 |
| Allan C. Thygesen President and CEO, Director | Oct 1, 2026 | Sale(10b5-1 plan) | −13,598 | $69.45 | $944.38K | 171,978 |
| Allan C. Thygesen President and CEO, Director | Oct 1, 2026 | Sale(10b5-1 plan) | −7,475 | $68.53 | $512.26K | 185,576 |
| Mary Agnes Wilderotter Director | Oct 1, 2026 | Sale(10b5-1 plan) | −1,000 | $68.80 | $68.80K | 2,199 |
| James P. Shaughnessy Chief Legal Officer | Oct 1, 2026 | Sale(10b5-1 plan) | −400 | $69.55 | $27.82K | 50,591 |
| James P. Shaughnessy Chief Legal Officer | Oct 1, 2026 | Sale(10b5-1 plan) | −11,600 | $68.77 | $797.73K | 50,991 |
| Robert Chatwani President General Mgr, Growth | Sep 17, 2026 | Sale(10b5-1 plan) | −4,044 | $68.77 | $278.11K | 86,560 |
| Robert Chatwani President General Mgr, Growth | Sep 17, 2026 | Sale(10b5-1 plan) | −10,632 | $69.66 | $740.63K | 75,928 |
| Mary Agnes Wilderotter Director | Sep 16, 2026 | Sale(10b5-1 plan) | −1,096 | $70.60 | $77.38K | 3,199 |
| James P. Shaughnessy Chief Legal Officer | Sep 15, 2026 | Tax withholding | −8,501 | – | – | 62,591 |
| James P. Shaughnessy Chief Legal Officer | Sep 15, 2026 | Option exercise | +18,277 | – | – | 71,092 |
| Allan C. Thygesen President and CEO, Director | Sep 15, 2026 | Option exercise | +67,467 | – | – | 226,505 |
| Allan C. Thygesen President and CEO, Director | Sep 15, 2026 | Tax withholding | −33,454 | – | – | 193,051 |
| James P. Shaughnessy Chief Legal Officer | Sep 15, 2026 | Tax withholding | −11,983 | – | – | 59,109 |
| James P. Shaughnessy Chief Legal Officer | Sep 15, 2026 | Option exercise | +18,277 | – | – | 71,092 |
| Robert Chatwani President General Mgr, Growth | Sep 15, 2026 | Tax withholding | −17,508 | – | – | 90,604 |
| Robert Chatwani President General Mgr, Growth | Sep 15, 2026 | Option exercise | +35,307 | – | – | 108,112 |
| Paula Hansen Chief Revenue Officer | Sep 15, 2026 | Tax withholding | −19,559 | – | – | 109,857 |
| Paula Hansen Chief Revenue Officer | Sep 15, 2026 | Option exercise | +39,444 | – | – | 129,416 |
| Blake Jeffrey Grayson Chief Financial Officer | Sep 15, 2026 | Tax withholding | −17,730 | – | – | 107,933 |
| Blake Jeffrey Grayson Chief Financial Officer | Sep 15, 2026 | Option exercise | +44,234 | – | – | 125,663 |
| Anna Marrs Director | Sep 14, 2026 | Sale(10b5-1 plan) | −548 | $67.00 | $36.72K | 13,525 |
| Teresa Briggs Director | Sep 10, 2026 | Sale(10b5-1 plan) | −548 | $64.60 | $35.40K | 10,811 |
| Peter Solvik Director | Sep 10, 2026 | Sale | −30,000 | $65.25 | $1.96M | 90,253 |
| Peter Solvik Director | Sep 10, 2026 | Sale | −16,000 | $65.22 | $1.04M | 49,558 |
| Blake Jeffrey Grayson Chief Financial Officer | Sep 8, 2026 | Sale(10b5-1 plan) | −11,550 | $65.25 | $753.64K | 84,879 |
| Blake Jeffrey Grayson Chief Financial Officer | Sep 8, 2026 | Sale(10b5-1 plan) | −3,450 | $66.64 | $229.91K | 81,429 |
| Blake Jeffrey Grayson Chief Financial Officer | Sep 8, 2026 | Sale(10b5-1 plan) | −11,550 | $65.25 | $753.64K | 84,879 |
| Blake Jeffrey Grayson Chief Financial Officer | Sep 8, 2026 | Sale(10b5-1 plan) | −3,450 | $66.64 | $229.91K | 81,429 |
| Brian Keith Roberts Director | Sep 5, 2026 | Option exercise | +856 | – | – | 1,711 |
| Blake Jeffrey Grayson Chief Financial Officer | Sep 4, 2026 | Sale(10b5-1 plan) | −30,000 | $70.00 | $2.10M | 96,429 |
| Blake Jeffrey Grayson Chief Financial Officer | Sep 4, 2026 | Sale(10b5-1 plan) | −30,000 | $70.00 | $2.10M | 96,429 |
| Michael George Rosenbaum Director | Sep 3, 2026 | Option exercise | +522 | – | – | 2,088 |
| Peter Solvik Director | Sep 1, 2026 | Option exercise | +1,096 | – | – | 10,066 |
| Anna Marrs Director | Sep 1, 2026 | Option exercise | +1,096 | – | – | 14,073 |
| James A. Beer Director | Sep 1, 2026 | Option exercise | +1,096 | – | – | 15,682 |
| Teresa Briggs Director | Sep 1, 2026 | Option exercise | +1,096 | – | – | 11,359 |
| Blake Irving Director | Sep 1, 2026 | Option exercise | +1,096 | – | – | 27,189 |
| Enrique T. Salem Director | Sep 1, 2026 | Option exercise | +1,096 | – | – | 168,414 |
| Mary Agnes Wilderotter Director | Sep 1, 2026 | Option exercise | +1,096 | – | – | 4,295 |
| Cain A. Hayes Director | Sep 1, 2026 | Option exercise | +1,096 | – | – | 16,813 |
| James A. Beer Director | Aug 28, 2026 | Sale(10b5-1 plan) | −450 | $64.02 | $28.81K | 14,586 |
| Blake Jeffrey Grayson Chief Financial Officer | Aug 7, 2026 | Sale(10b5-1 plan) | −15,000 | $60.00 | $900.00K | 126,429 |
| Rowan M. Trollope Director | Aug 2, 2026 | Option exercise | +869 | – | – | 869 |
| James P. Shaughnessy Chief Legal Officer | Jul 1, 2026 | Sale(10b5-1 plan) | −246 | $46.01 | $11.32K | 52,815 |
| James P. Shaughnessy Chief Legal Officer | Jul 1, 2026 | Sale(10b5-1 plan) | −11,754 | $45.53 | $535.16K | 53,061 |
| Blake Jeffrey Grayson Chief Financial Officer | Jul 1, 2026 | Sale(10b5-1 plan) | −600 | $45.99 | $27.59K | 141,429 |
| Blake Jeffrey Grayson Chief Financial Officer | Jul 1, 2026 | Sale(10b5-1 plan) | −14,400 | $45.53 | $655.63K | 142,029 |
| Paula Hansen Chief Revenue Officer | Jul 1, 2026 | Sale(10b5-1 plan) | −6,000 | $45.54 | $273.24K | 89,972 |
| Allan C. Thygesen President and CEO, Director | Jul 1, 2026 | Sale(10b5-1 plan) | −21,993 | $46.11 | $1.01M | 159,038 |
| Allan C. Thygesen President and CEO, Director | Jul 1, 2026 | Sale(10b5-1 plan) | −4,257 | $45.58 | $194.03K | 181,031 |
| Robert Chatwani President General Mgr, Growth | Jun 22, 2026 | Sale(10b5-1 plan) | −6,680 | $43.52 | $290.71K | 72,805 |
| Robert Chatwani President General Mgr, Growth | Jun 22, 2026 | Sale(10b5-1 plan) | −9,222 | $42.64 | $393.23K | 79,485 |
| Allan C. Thygesen President and CEO, Director | Jun 15, 2026 | Option exercise | +65,561 | – | – | 217,798 |
| Allan C. Thygesen President and CEO, Director | Jun 15, 2026 | Tax withholding | −32,510 | – | – | 185,288 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of DocuSign's stock actually held short. Settlement fails (shares not delivered on time) peaked at 23,580 shares on Sep 21, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Paula Hansen Officer | Nov 2, 2026 | 3,300 | $270.00K | Nov 2, 2026 | Performance and Restricted Stock |
| Allan C. Thygesen Director, Officer | Oct 1, 2026 | 26,250 | $1.76M | Oct 1, 2026 | Restricted Stock Units |
| Mary Agnes Wilderotter Director | Oct 1, 2026 | 1,000 | $68.80K | Oct 1, 2026 | Restricted Stock |
| Paula Hansen Officer | Oct 1, 2026 | 3,300 | $227.06K | Oct 1, 2026 | Performance Shares |
| James P. Shaughnessy Officer | Oct 1, 2026 | 12,000 | $825.51K | Oct 1, 2026 | Restricted Stock |
| Robert Chatwani Officer | Sep 17, 2026 | 14,676 | $1.02M | Sep 17, 2026 | Performance and Restricted Stock |
| Mary Agnes Wilderotter Director | Sep 16, 2026 | 1,096 | $77.38K | Sep 16, 2026 | Restricted Stock |
| Anna Marrs Director | Sep 14, 2026 | 548 | $36.72K | Sep 14, 2026 | Restricted Stock |
| Peter Solvik Director | Sep 10, 2026 | 46,000 | $2.99M | Sep 10, 2026 | Pre IPO investment by Sigma Partners |
| Teresa Briggs Director | Sep 10, 2026 | 548 | $35.40K | Sep 10, 2026 | Restricted Stock |
| Blake Jeffrey Grayson Officer | Sep 8, 2026 | 15,000 | $983.55K | Sep 8, 2026 | Restricted Stock |
| Blake Jeffrey Grayson Officer | Sep 4, 2026 | 30,000 | $2.10M | Sep 4, 2026 | Performance and Restricted Stock |
| James A. Beer Director | Aug 28, 2026 | 450 | $28.81K | Aug 28, 2026 | Restricted Stock |
| Blake Jeffrey Grayson Officer | Aug 7, 2026 | 15,000 | $900.00K | Aug 7, 2026 | Restricted Stock and Performance Shares |
| Paula Hansen Officer | Jul 1, 2026 | 6,000 | $273.21K | Jul 1, 2026 | Performance Shares |
See a number that looks wrong?